Skip to main content

Table 2 Serum biochemical parameters of rats in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups

From: The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

 Control(n = 8)HFD (n = 8)HFD + β3-AGO(n = 8)HFD + β3-ANT(n = 8)
ALT (U/L)36.56 ± 2.1762.84 ± 7.73*46.09 ± 1.7580.98 ± 5.63
AST (U/L)145.61 ± 11.9205.80 ± 3.71*163.14 ± 5.3232.06 ± 6.9
TG (mmol/L)0.37 ± 0.050.71 ± 0.05*0.49 ± 0.070.96 ± 0.10
TC (mmol/L)1.46 ± 0.062.71 ± 0.29*2.34 ± 0.203.17 ± 0.12
LDL-C (mmol/L)0.37 ± 0.050.65 ± 0.078*0.50 ± 0.030.80 ± 0.08
FFA (mmol/L)0.63 ± 0.050.88 ± 0.068*0.75 ± 0.041.03 ± 0.07
  1. ALT alanine aminotransferase, AST aspartate aminotransferase, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, FFA free fatty acid. *P < 0.05 vs the control group. P < 0.05 vs the HFD group